Spero Therapeutics

2 followers

‌

Spero Therapeutics (Nasdaq: SPRO) is a multi-asset pre-commercial stage biopharmaceutical company in Cambridge, Mass. We are highly committed to advancing novel treatment approaches for bacterial infections with a world-class team of biotechnological and biopharmaceutical experts. The company has a... Read more

Industries

Headquarters

Cambridge, United States

Employees

Links

Org chart

President & CEO

Sath Shukla

Collapse

Esther Rajavelu

CFO & Chief Business Officer

Chief Medical Officer

Timothy Keutzer

Chief Operating Officer, Spero Therapeutics

Chief Human Resources Officer

Chief Scientific Officer

Jay Blackington

VP, People Strategy & Culture

Vice President, Alliance Management And Business Development

Vice President / Head Of Quality Assurance At Spero Therapeutics

Executive Director, Head Of Clinical Pharmacology, DMPK And Drug Analysis

Senior Director

John C. Pottage

Director

Director

Tregoning Prior

Director

Frank E. Thomas

Director

Director, Biostatistics & Statistical Programming

Director, CMC

Myriah Satterfield

Director, Clinical Data Management

Senior Executive Assistant

Director, Clinical Operations

Corporate Communications Manager

Teams

Leadership Team

4 members

Directors Team

11 members

Clinical and Research Operations

7 members

Business Development & Market Access

1 members

Operations Team

4 members

Management Team

4 members

Similar companies

4D Molecular Therapeutics

3 followers

Matica Biotechnology

1 follower

Nkarta

1 follower

Thermo Fisher Scientific

166 followers

Genentech

150 followers

Kura Oncology

18 followers

Charles River Laboratories

11 followers

Cytiva

10 followers

Ultragenyx Pharmaceutical

10 followers

United Therapeutics

7 followers

Transnetyx

1 follower

Explore companies